Friday, February 03
The radiopharmaceutical, I-131-MIP-1466, which is designed to deliver a therapeutic dose of radiation to metastatic prostate cancer, will enter a clinical trial to evaluate its efficacy and benefits for patients.
Thursday, February 02
Computerized physician order entry (CPOE) of imaging orders has the potential to improve healthcare efficiency, safety and cost-effectiveness, but only if clinicians get behind implementation of such systems. That might not be a problem, however, as an imaging CPOE system with embedded decision support can be broadly accepted clinically, according to a 10-year study of CPOE use at a large, university-affiliated facility published in the February issue of the Journal of the American College of Radiology.
Tuesday, January 31
Men’s options for contraception have typically been limited to condoms or vasectomy, but research published January 30 in Reproductive Biology and Endocrinology touted the potential of another male contraceptive: therapeutic ultrasound.
Monday, January 30
With the exception of liver metastases, whole-body imaging of estrogen receptor (ER) expression with 18F-FES, an ER-specific PET tracer, can be a valuable additional diagnostic tool when standard work-up is inconclusive, particularly in breast cancer patients, according to a study published in the February issue of the Journal of Nuclear Medicine.
Monday, January 30
The malignancy rate for MR-detected breast masses less than or equal to 5 mm has been shown to be greater than 20 percent, indicating that these small masses should be viewed with a high degree of suspicion when seen in staging breast MRI exams, according to a study published in the January issue of Academic Radiology.
Sunday, January 29
Inflammation, as assessed by 18F-FDG-PET uptake and histology, is increased in plaques containing high-risk morphological (HRM) features and rises with increasing number of HRM, according to a study in the January issue of
Circulation: Cardiovascular Imaging. Study authors suggested that data support the concept that inflammation accumulates relative to the burden of morphological abnormalities.
Friday, January 27
A new magnetic resonance spectroscopy (MRS) technique may offer a method to detect and track a protein associated with a genetic mutation in brain tumor cancer cells. The method could inform diagnosis of glioma and provide prognostic information, according to a study published online Jan. 26 in Nature Medicine.
Friday, January 27
Patients with head and neck cancers who have been treated with intensity-modulated radiation therapy (IMRT) enjoy a better quality of life than those treated with 3D conformal radiation therapy, according to a study presented Jan. 27 at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.
Thursday, January 26
The benefits to productivity and efficiency provided by PACS are widely publicized, but a PACS implementation isn’t without its challenges. In the February issue of Academic Radiology, radiologists and PACS managers from University Hospitals Case Medical Center in Cleveland offered their experiences implementing PACS to illustrate potential gains and problem areas.
Wednesday, January 25
Informatics innovations can boost productivity or market share; however, justifying the development and implementation of such systems can be challenging. An article in the February issue of Academic Radiology offered a wish list and a series of strategies for investing in specific PACS innovations.
Tuesday, January 24
Although 44.4 million adults make it a point to receive periodic health examinations each year, many of them may not be receiving the recommended screening tests and counseling services that could benefit their health, according to a study published January in the
American Journal of Preventive Medicine.
Monday, January 23
Often healthcare services in the U.S. are overutilized, which can lead to high healthcare spending. Expanding guidelines and establishing appropriate use criteria for more healthcare services could help eliminate this overuse and in turn reduce high healthcare spending, according to an editorial published in the Jan. 24 issue of the
Archives of Internal Medicine.
Sunday, January 22
18F-flutemetamol PET imaging demonstrates strong concordance with histopathology irrespective of timing and sequence of exams in prospective and retrospective settings, and shows promise as a valuable tool to study and possibly facilitate diagnosis of Alzheimer’s disease, both in patients with suspected normal pressure hydrocephalus, and among the wider population, according to a pooled analysis of four studies presented at the 2012 Human Amyloid Imaging (HAI) conference in Miami, Fla.
Friday, January 20
Bone mineral density (BMD) screening for osteoporosis should be necessary only every 15 years for postmenopausal women with normal bone density on an initial test, though the screening interval for women with advanced osteopenia should be reduced to one year, according to a study published in the Jan. 19 issue of the New England Journal of Medicine.
Friday, January 20
An analysis of clinical trial results performed by the Radiation Therapy Oncology Group (RTOG) demonstrated that a chromosomal abnormality has definitive prognostic and predictive value for managing the treatment of adult patients with pure and mixed anaplastic oligodendrogliomas. "These are exciting and practice-changing results," said Walter J. Curran, Jr., MD, RTOG group chair and executive director of the Winship Cancer Institute of Emory University in Atlanta, in a statement.
Thursday, January 19
Breast cancer patients aged 50 or younger experience psychosocial and menopause-related concerns, weight gain and infertility, according to a literature review published Jan. 20 in the Journal of the National Cancer Institute. The researchers called for additional studies and targeted interventions to address these symptoms and concerns.
Tuesday, January 17
Software developed by researchers at the University of Michigan in Ann Arbor was able to separate malignancy from background tissue on digital pathology slides, according to a paper published in the January issue of Analytical Cellular Pathology.
Monday, January 16
An interim 18F-FDG PET/CT exam after two cycles of neoadjuvant chemotherapy was predictive of pathologic response and disease-free survival in patients with triple-negative breast cancer, an aggressive subtype of breast cancer, according to a prospective study published online Jan. 12 in the Journal of Nuclear Medicine.
Monday, January 16
The team at Johns Hopkins In-Vivo Cellular and Molecular Imaging Center in Baltimore is using novel imaging tools to discover new early detection methods for cancers existing in cells, and study its prevention and elimination before spreading to other organs and tissues.
Friday, January 13
Combined analysis of 7T R2* and phase data could improve characterization of multiple sclerosis (MS) lesions, according to a study published in the January issue of Radiology.